Beranda2359 • HKG
add
WuXi AppTec Ord Shs H
Tutup sebelumnya
$105,80
Rentang hari
$100,00 - $108,20
Rentang tahun
$44,30 - $124,70
Kapitalisasi pasar
305,93Â M HKD
Volume Rata-Rata
7,16Â jt
Rasio P/E
20,00
Hasil dividen
1,42%
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 11,14Â M | 32,01% |
Biaya operasional | — | — |
Laba bersih | — | — |
Margin laba bersih | — | — |
Penghasilan per saham | 1,02 | 22,89% |
EBITDA | — | — |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 25,16Â M | 71,50% |
Total aset | 83,82Â M | 12,67% |
Total liabilitas | 23,41Â M | 21,30% |
Total ekuitas | 60,41 M | — |
Saham yang beredar | 3,43 M | — |
Harga terhadap nilai buku | 6,06 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | — | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | — | — |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
The company is listed in mainland China and Hong Kong. Its H‑shares are constituents of the Hang Seng Index, and its A‑shares are included in the FTSE China A50 Index.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. Wikipedia
Didirikan
1 Des 2000
Situs
Karyawan
37.832
